STK11 and neoplasm: Inactivation of STK11 signaling stimulates cancer cells to produce G-CSF, CXCL7, IL-6, and IL-1β, thereby recruiting tumor-associated neutrophils, which results in suppression of cytotoxic T-cell activity (51, 52).